BTAI
BioXcel Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.07
−37.11%Leverage
- Debt / equity
- -0.90x
- Net debt / equity
- -0.79x
- Debt / assets
- 3.63x
- Debt / EBITDA
- -1.96x
- Net debt / EBITDA
- -1.72x
Liquidity & coverage
- Current ratio
- 0.21x
- Quick ratio
- 0.21x
- Cash ratio
- 0.09x
- Interest coverage
- -2.59x
- EBITDA / interest
- -3.10x
- Working capital
- -$108.4M
Cash & dividend
- FCF / debt
- -0.49x
- Cash flow / debt
- -0.49x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026